An interventional study of Stable iron isotope in Iron Absorption, sponsored by Pennington Biomedical Research Center. Recruiting at 2 sites in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-29.
Sponsored by Pennington Biomedical Research Center · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 82 studies in Iron Deficiencies with a site in United States — 16 open to participants now, 20 under way, 4 of them phase 3. Iron Deficiencies · United States.
Among the 82 studies in Iron Deficiencies with a site in United States, this one is the 6th largest by planned enrollment of the 63 interventional ones that give a count, is one of 8 that started in 2026, is one of 29 with no phase, reaches primary completion later than 16 of the 19 other live ones, and was the 71st registered.
386 studies on the registry are indexed under Iron Deficiencies; 78 are open to participants now.
Browse Iron Deficiencies studies →16 of the 82 studies in Iron Deficiencies with a site in United States are open now. Recruiting first, the newest first:
Qualia Life Sciences · Sites in United States
Ages 18+ · Healthy volunteers
Lindenwood University · Sites in United States
Ages 18–45 · Women only · Healthy volunteers
Kaiser Permanente · Sites in United States
Ages 18+
University of Illinois Chicago · Sites in United States
Ages 18–45 · Women only · Healthy volunteers
Columbia University · Sites in United States
Ages 10–19
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 53 Iron Deficiencies studies recruiting now, 23 (43%) set no upper age limit and 26 (49%) stop at 75 or younger; 14 take children under 18; 15 take healthy volunteers.
This study: 18 Years to 50 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
82 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 13 · Phase 3 14 · Phase 4 10
First in 2000; this study’s year is marked. 8 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 300 is above the median of 99 across 301 interventional studies indexed under Iron Deficiencies.
Median enrollment 89 across the 63 interventional studies, 73 across the 18 observational. Of the 57 that completed or were terminated, 13 (23%) have results posted.
This tab as a report to print or save as PDF → With an account.
23 of 82 have an industry lead sponsor. The 10 most frequent:
Pennington Biomedical Research Center is the lead sponsor of 284 studies on the registry; 30 are open to participants now.
Pennington Biomedical Research Center has 2 studies filed under Iron Deficiencies — fewer than ten, so there is no comparison to draw.
10 of the studies in Iron Deficiencies with a site in United States that are under way reach primary completion within a year, 3 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05179226Phase 3Pharmacosmos A/SMulti-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia | 2027-04-30 |
| NCT07217873Phase 3Columbia UniversityIntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study | 2027-08-31 |
| NCT06527391Phase 3University of MinnesotaCholine and Iron Deficiency | 2027-09-21 |
| NCT07197905Vanderbilt University Medical CenterRestoring Iron Deficiency in POTS | 2026-12 |
| NCT07892911Ancestral Supplements, LLCA Study to Evaluate the Effects of a Beef Liver Supplement on Energy, Mood, and Mental Clarity | 2026-12-01 |
Add all 10 to your calendar (.ics) → With an account.
Among the 82 studies in Iron Deficiencies with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Dietary Reference Intakes (DRIs) for iron are based on a relatively small number of studies in European populations. This research study will determine iron needs in a representative sample of adults living in the US using the iron isotope dilution technique. Following administration and equilibration of a stable iron isotope, participants will be followed for a 12 week study period. Blood will be collected every 4 weeks and the isotopic composition will be determined. Results will help update dietary iron guidelines making sure they better match the specific needs of the US population.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A representative sample of adult males and premenopausal females living in the US
Other: Stable iron isotope
Stable iron isotopes will be used to determine iron requirements.
Iron isotope composition in blood
Tracer-to-tracee rate in venous blood samples collected at multiple time points
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Aug 2028, 29 months after the start.
Of 77 non-industry interventional studies with no phase under Iron Deficiencies, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's planned 29 months is above that.
Counting every sponsor, half of 89 studies reached it within 10 months; a quarter within 5 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pennington Biomedical Research Center →